Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06271707 · ClinicalTrials.gov registry record · Phase 4
Stellate Ganglion Block
A Phase 4 study of Esophagectomy and Lobectomy, sponsored by University of Minnesota.
- Recruiting
- Registry status
- Phase 4
- Development phase
- 48
- Enrollment target
- 1
- Study location
NCT06271707: Recruiting Phase 4 study of Esophagectomy and Lobectomy, sponsored by University of Minnesota.
NCT06271707 is a Phase 4 study of Esophagectomy and Lobectomy that is actively recruiting participants, run by University of Minnesota. The registered enrollment target is 48 participants, below the 2,131-participant average among 7 other Esophagectomy trials with a reported enrollment target (98% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06271707, a Phase 4 study of Esophagectomy and Lobectomy, is actively recruiting participants, sponsored by University of Minnesota.
- RECRUITING
- Registry status
- Phase 4
- Development phase
- 48 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to determine if the addition of an ultrasound guided left sided stellate ganglion block with bupivacaine in patients undergoing esophagectomy, pneumonectomy, or lobectomy will result in lower rates of postoperative atrial fibrillation as compared to standard of care.
Primary Outcome
Incidence of Atrial fibrillation in the first 168 hours after surgery.
Conditions Studied
Interventions
- OTHER Saline
- DRUG 0.5% bupivacaine
Study Locations (1)
Minnesota
- University of Minnesota - Minneapolis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 48 participants |
| Start Date | 2025-05-19 |
| Est. Completion | 2027-07-15 |
| Phase | Phase 4 |
What NCT06271707 shows while recruiting
NCT06271707 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 48 participants, a relatively small participant target, below the 2,131-participant average among 7 other Esophagectomy trials with a reported enrollment target (98% lower).
The record links to 3 conditions, with Esophagectomy appearing as the primary indexed condition, and to 2 interventions - of which Saline is the first listed.
NCT06271707 reports a single indexed study location in Minnesota.
Frequently Asked Questions
What is clinical trial NCT06271707 about?
NCT06271707 is a clinical study titled "Stellate Ganglion Block". The purpose of this study is to determine if the addition of an ultrasound guided left sided stellate ganglion block with bupivacaine in patients undergoing esophagectomy, pneumonectomy, or lobectomy will result in lower rates of postoperative atrial fibrillation as compared to standard of care.
What is the current status of trial NCT06271707?
This trial is currently recruiting. It is a Phase 4 study. The enrollment target is 48 participants. The study started on 2025-05-19. Estimated completion is 2027-07-15.
What conditions does trial NCT06271707 study?
This clinical trial studies the following conditions: Esophagectomy, Lobectomy, Pneumonectomy.
What interventions are being tested in trial NCT06271707?
The interventions under investigation include: Saline (OTHER), 0.5% bupivacaine (DRUG).
Who is sponsoring clinical trial NCT06271707?
This trial is sponsored by University of Minnesota, which has 966 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06271707 being conducted?
This trial has 1 study location across Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Esophagectomy
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Prevention of Atrial Fibrillation Following Esophagectomy
COMPLETED · Phase 4
-
Metachronic Brain Metastases After Esophagectomy for Esophageal Cancer (METABREC)
RECRUITING
-
Effectiveness of Methods for Pyloric Drainage in esophagecTomY: Botox vs. Pyloromyotomy
RECRUITING · Phase 2
-
Investigating Outcomes of Elective Robotic Transhiatal Esophagectomy
RECRUITING
-
Outcomes After Esophagectomy With a Focus on Minimally Invasive Esophagectomy and Quality of Life
RECRUITING
-
Mayo Clinic Upper Digestive Disease Survey
RECRUITING
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01765777 · 48 participants · NA
Efficacy of Osteopathic Manipulative Medicine (OMM) and Phototherapy for Patients With Chronic Lower Back Pain
- NCT03073343 · 48 participants · NA
A Prospective, Randomized, Open Label Trial of Two Doses of Oral Betaine
- NCT03431064 · 48 participants
Lung Recruitment Maneuver as a Potential Predictor of Fluid Responsiveness in Mechanically Ventilated Pediatric Patients
- NCT03514602 · 48 participants · NA
Maternal Smoking Cessation and Pediatric Obesity Prevention
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI